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E. coli promotes human Vγ9Vδ2 T 
cell transition from cytokine-
producing bactericidal effectors to 
professional phagocytic killers in a 
TCR-dependent manner
M. Barisa  1, A. M. Kramer1, Y. Majani2, D. Moulding2, L. Saraiva  1, M. Bajaj-Elliott1,  
J. Anderson2 & K. Gustafsson  1
γδT cells provide immune-surveillance and host defense against infection and cancer. Surprisingly, 
functional details of γδT cell antimicrobial immunity to infection remain largely unexplored. Limited 
data suggests that γδT cells can phagocytose particles and act as professional antigen-presenting 
cells (pAPC). These potential functions, however, remain controversial. To better understand γδT cell-
bacterial interactions, an ex vivo co-culture model of human peripheral blood mononuclear cell (PBMC) 
responses to Escherichia coli was employed. Vγ9Vδ2 cells underwent rapid T cell receptor (TCR)-dependent 
proliferation and functional transition from cytotoxic, inflammatory cytokine immunity, to cell expansion 
with diminished cytokine but increased costimulatory molecule expression, and capacity for professional 
phagocytosis. Phagocytosis was augmented by IgG opsonization, and inhibited by TCR-blockade, 
suggesting a licensing interaction involving the TCR and FcγR. Vγ9Vδ2 cells displayed potent cytotoxicity 
through TCR-dependent and independent mechanisms. We conclude that γδT cells transition from early 
inflammatory cytotoxic killers to myeloid-like APC in response to infectious stimuli.
γδT cells express a T cell receptor (TCR) composed of γ and δ chains, and constitute 1–15% of human periph-
eral blood mononuclear cells (PBMC); and up to 40% of intraepithelial lymphocytes in epithelial linings1. A 
broad categorization in humans is defined by Vδ chain expression, constituting Vδ1+, Vδ2+ and Vδ1−Vδ2− 
subsets. Human γδT cells possess high functional plasticity encompassing cytokine production, innate-like 
cytotoxicity, wound-healing, immunoregulation and professional antigen presenting cell (pAPC) properties2. 
Evidence suggests that the predominant human peripheral γδT cell subset, with a Vγ9Vδ2 TCR, is involved in 
immuno-surveillance of stress signals emanating from endogenous (e.g. tumor cells) and microbial pyrophos-
phates (e.g. infected cells)3.
Significant increase in systemic and mucosal γδT cells is seen in several acute infectious diseases. This effect 
is particularly pronounced in systemic bacterial and parasitic infections, which include Brucella, Streptococci, 
Coxiella, Listeria, Francisella, Shigella, Leptospira, Plasmodium and Mycobacterium infections amongst others4–13. 
While the functional phenotype of in vivo expanded γδT cells remains poorly examined, recorded observations 
indicate an activated phenotype, as evidenced by high cell surface levels of CD69, and significantly elevated 
expression of MHC class II (e.g. HLA-DR) and CD8611, 12, 14–16. The presence of CD69posHLA-DRpos γδT cells in 
sepsis and systemic inflammatory response syndrome correlates negatively with mortality15, 17. Although studies 
have documented ex vivo expansion of primary γδT cells upon PBMC exposure to infectious agents, detailed 
information on phenotypic cell changes is lacking4, 18–21.
1Infection, Immunity and Inflammation Program; UCL Great Ormond Street Institute of Child Health, 30 Guilford 
Street, London, WC1A 1EH, United Kingdom. 2Developmental Biology and Cancer Program, UCL Great Ormond 
Street Institute of Child Health, 30 Guilford Street, London, WC1A 1EH, United Kingdom. Correspondence and 
requests for materials should be addressed to M.B. (email: m.bajaj-elliott@ucl.ac.uk) or J.A. (email: j.anderson@
ucl.ac.uk) or K.G. (email: k.gustafsson@ucl.ac.uk)
Received: 23 January 2017
Accepted: 19 April 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 2805  | DOI:10.1038/s41598-017-02886-8
The in vivo observations of γδT cell expansion in clinical infectious disease, and the ex vivo exploration of 
human γδT cell pAPC function and phagocytosis by Brandes et al. and our own laboratory22–24, prompted us to 
investigate how Gram-negative bacteria may modulate the plasticity of this unique T cell population. We hypoth-
esized that the γδT cell response within PBMC to whole, freshly UV-irradiated E. coli reflects events that occur 
during a systemic infection. E. coli, a causative agent of human sepsis and bacteremia, expresses phosphoantigens 
that are documented potent activators of peripheral Vγ9Vδ2 γδT cells19, 25. E. coli is, moreover, a human intestinal 
commensal and frequent cause of infections at a site highly populated by γδT cells. We therefore examined γδT 
phenotype and function in response to acute E. coli exposure and in response to re-exposure of expanded cells. 
Responses were compared to zoledronic acid, a drug, which is a known stimulator of Vγ9Vδ2 γδT cell expansion 
via accumulation of endogenous pyrophosphates26. In response to E. coli, peripheral human Vγ9Vδ2 γδT cells 
transitioned from early Th1-like, cytotoxic responders to cytotoxic, phagocytic pAPCs. This model allowed us to 
address which of these effector functions are dependent on the TCR.
Results
Zoledronate-expanded γδT cells take up IgG-opsonized 1.0 μm beads and E. coli. Phagocytosis, 
a crucial component of APC function is defined as receptor and actin-polymerization-dependent uptake of mate-
rial >0.5 μm in size27. We have previously reported limited phagocytosis by freshly-isolated peripheral γδT cells, 
resulting in processing and presentation on MHC class I and II of associated peptides23, 24. Herein, we explored 
the impact of cell expansion on γδT cell phagocytic capacity in detail. 14 day zoledronic acid (zoledronate)-ex-
panded γδT cells were co-cultured with protease-activated DQ-Green fluorescent, bovine serum albumin (BSA)-
labeled polystyrene beads (0.5 μm or 1.0 μm in size), with or without IgG opsonization. DQ-Green, BSA-labeled 
beads have been employed previously as an indicator of phagosome maturation and antigen processing in mac-
rophages28. Internalization of fluorescing, i.e. protease-exposed, beads was quantified using an ImageStream 
internalization score (Fig. 1A). Expanded γδT cell incubation with non-opsonized beads revealed significant 
uptake of 0.5 μm, but not 1.0 μm beads. Opsonization with Rituximab (monoclonal, chimeric human-mouse 
IgG against CD20) significantly enhanced 1.0 μm bead uptake - to a level statistically indistinguishable from the 
uptake of beads 0.5 μm in size (Fig. 1B). Internalization scores indicated that ~9% of γδT cells associated with 
opsonized beads, of which ~86% showed internalization. The observation that a significant portion of expanded 
γδT cells internalize opsonized beads into a protease-rich environment prompted us to investigate γδT cell uptake 
of bacteria, such as E. coli. Confocal microscopy allowed detection of whole and partially-degraded E. coli in the 
interior of zoledronate-expanded γδT cells incubated with IgG-opsonized, GFP-expressing E. coli (Fig. 1C). As 
exemplified in Fig. 1C, virtually all γδT cells within the field of vision were associated with multiple adherent E. 
coli, whereupon only a minor fraction of the bacteria were found to be intracellular (data not shown).
E. coli-expanded,  but  not  freshly-isolated γδT  cells,  phagocytose  IgG-opsonized E. 
coli. We next quantified the uptake of IgG opsonized versus non-opsonized E. coli by freshly-isolated ver-
sus E. coli-expanded γδT cells. Freshly-isolated PBMC from healthy laboratory donors were co-cultured with 
Figure 1. Zoledronate-expanded γδT cells take up IgG-opsonized 1.0 μm beads and E. coli. (A) 14 day 
zoledronate-expanded γδT cells (n = 3) were incubated with IgG-opsonized or non-opsonized polystyrene 
beads or IgG-opsonized E. coli for 60 min, and analyzed for internalized material. γδT cell uptake of beads 
was assessed with an internalization score generated via ImageStream analysis. Representative donor data is 
shown, with γδTCR in blue and beads in green. (B) PBMC were cultured for 60 min with non-opsonized 0.5 μm 
and 1.0 μm beads, as well as IgG (Rituximab; RTX)-opsonized 1.0 μm beads. PBMC were then stained for 
ImageStream analysis; internalisation scores are shown for γδT cells. (C) FACS-purified γδT cells were stained 
with phalloidin (red), DAPI (blue), incubated with opsonized, GFP-expressing E. coli, and analyzed via confocal 
microscopy. Representative data is shown of a single cell in 3D-rotation with or without phalloidin. Internalised 
E. coli is indicated with white arrows.
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UV-irradiated E. coli and left to expand for 14 days. Expansion resulted in a marked increase in CD3pos cells 
(Fig. S2A), with a preferential (>200-fold) expansion of γδT cells (Fig. 2A,B). It was interesting to note that a 
population of αβT cells persisted with minimal expansion (Fig. 2B). Vδ2+ γδT cells displayed the highest rate 
of expansion (~250-fold), followed by Vδ1−Vδ2− cells (~40-fold) and Vδ1+ γδT cells, which instead contracted 
(Fig. 2C). Donor-matched, parallel expansions of PBMC in IL-2 media with zoledronate or E. coli induced similar 
rates of expansion of subsets (Fig. S2B). Of note, IL-2 media alone failed to induce expansion of γδT or αβT cells 
(data not shown).
To measure phagocytosis, freshly-isolated or expanded PBMC were incubated with IgG-opsonized or 
non-opsonized FITCylated-E. coli for 60 minutes, and analyzed via Trypan Blue quenching and flow cytometry 
(Fig. 2D). Freshly-isolated γδT and αβT cells failed to show notable bacterial uptake; in contrast ~25% and ~45% 
of freshly-isolated CD3neg PBMC (predominantly monocytes) internalized non-opsonized and opsonized E. coli, 
Figure 2. E. coli-expanded, but not fresh, γδT cells phagocytose IgG-opsonized E. coli. Freshly-isolated PBMC 
(n = 5) were analyzed for E. coli uptake immediately or stimulated with E. coli, left to expand for 14 days, and 
examined on day 14. To determine uptake, PBMC were incubated with IgG-opsonized or non-opsonized, 
fluorescently-labeled E. coli for 60 min. PBMC were pre-cultured with normal media (control), Cytochalasin 
D (CyD) or DMSO. (A) Fold-expansion of γδT and αβT cells, assessed by FACS and Trypan Blue exclusion, 
was compared in 14 day E. coli-stimulated PBMC. (B) PBMC were compared via FACS for γδT and αβT cell 
content of total live lymphocytes. (C) Fold-expansion in response to E. coli over 14 days was compared between 
γδT cell subsets. (D) PBMC were incubated with FITC-labeled E. coli and quenched post-culture with Trypan 
Blue. Shown are representative stains, gated on γδT cells: i) non-quenched co-culture indicating total FITC 
fluorescence (black, solid, unshaded), ii) quenched co-culture indicating intracellular FITC fluorescence (black, 
dotted, unshaded), iii) co-culture with non-FITCylated E. coli (gray, shaded). (E) The proportion of FITCpos 
PBMC was examined. (F) PBMC were incubated with pHrodo-labeled E. coli. Shown are representative stains: 
i) PBMC, gated on γδT cells, co-cultured with pHrodo-E. coli (black, solid, unshaded), ii) pHrodo-E. coli only 
control (gray, shaded). (G) The proportion of pHrodopos PBMC was examined. (H) Uptake of IgG-opsonized 
FITC-E. coli and (I) acidification of IgG-opsonized pHrodo-E. coli was examined in 14 day zoledronate-
expanded γδT cells.
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respectively; both processes were found to be sensitive to cytochalasin D (CyD), an inhibitor of actin polymeriza-
tion (Fig. 2E). More than 50% of E. coli-expanded γδT cells took up opsonized E. coli in a CyD-sensitive manner. 
Interestingly, a subpopulation (mean 35%) of the residual αβT cells following E. coli expansion also took up 
opsonized E. coli, but this phenomenon was not significantly inhibited by CyD (Fig. 2E).
Phagocytosis promotes fusion of the phagosome with the lysosomal compartment. To determine whether E. 
coli uptake by E. coli-expanded γδT cells resulted in bacterial acidification (implying phagolysosome formation), 
freshly-isolated and 14 day expanded PBMC were co-cultured for 60 minutes with IgG-opsonized pH-sensitive 
pHrodo-E. coli (Fig. 2F). E. coli-expanded γδT cells, but not αβT cells or freshly isolated γδT cells, showed nota-
ble acidification of E. coli, which increased further upon opsonization. As a positive control, freshly isolated 
CD3neg PBMC (largely monocytes) also acidified non-opsonized and opsonized E. coli. Only acidification by 
CD3neg PBMC was CyD-sensitive (Fig. 2G). A similar degree of bacterial uptake, acidification and CyD-sensitivity 
was observed between E. coli and zoledronate-expanded γδT cells (Fig. 2H,I). It remains unclear as to why γδT 
cell bacterial uptake but not acidification appeared CyD-sensitive. One possible explanation may be the differ-
ence in bacterial preparations employed, as fresh exponentially-grown E. coli were irradiated just prior to uptake 
studies whilst lyophilized, E. coli-pHrodo conjugates were utilized to examine acidification. Lyophilisation may 
lead to bacterial acquisition of a spherical rather than rod shape, with consequential changes to the involvement 
of the actin cytoskeleton in the uptake process29, 30. Nonetheless, this series of experiments provides evidence for 
the first time that, upon expansion, γδT cells can phagocytose and direct bacteria to an acid-rich environment. 
Interestingly, the magnitude of bacterial acidification varied between expanded γδT cells and freshly-isolated 
CD3neg PBMC (Fig. S3), suggesting cell-specific pathways may be involved in bacterial uptake and processing.
E. coli and zoledronate-expanded γδT cells phagocytose E. coli in a TCR-dependent man-
ner. As E. coli and zoledronate-expanded γδT cells phagocytosed opsonized bacteria with similar dynamics, 
we hypothesized that both agents may employ overlapping signaling pathways in these processes. To examine the 
importance of the TCR in γδT cell phagocytosis, E. coli or zoledronate-expanded γδT cells were cultured with 
anti-γδTCR mAb (clone: B1), isotype-matched control mAb of known non-E. coli specificity (clone: MG1-45) 
or media alone, prior to co-culture. Both uptake and acidification of opsonized bacteria by E. coli-expanded γδT 
cells were highly sensitive to TCR inhibition whilst zoledronate-expanded γδT cells were less sensitive (Fig. 3A,B).
To further investigate the role of the TCR in γδT cell phagocytosis, expanded PBMC were incubated with 
IgG-opsonized green fluorescent beads for 60 minutes, and analyzed via Trypan Blue quenching and flow cytom-
etry, with or without γδTCR blocking (Fig. 3C). Uptake of opsonized beads by expanded γδT cells was signifi-
cantly inhibited in the presence of anti-γδTCR mAb (Fig. 3D). Bead adherence, as measured in non-quenched 
PBMC-bead co-culture, was not affected by blocking of the TCR.
The TCR CDR3 regions of (a) freshly-isolated unexpanded, (b) E. coli-expanded and (c) zoledronate-expanded 
γδT cells from one representative donor were sequenced. E. coli and zoledronate-expanded γδT cells showed sig-
nificant overlap of their Vγ and Vδ CDR3 sequences; both expansions resulted in a predominantly Vγ9Vδ2 γδT 
cell population (Fig. 3E). CDR3 homology and frequency in selected sequences that represented 5000 or more 
CDR3 reads were investigated (Fig. 3F). The most prominent group in Vγ chain CDR3 sequences was shared 
between all three subsets, suggesting a largely conserved expansion. The other prominent group was shared 
between E. coli and zoledronate-expanded γδT cells, with only low counts exclusive to either group. ~80–90% 
overlap in the Vγ and the Vδ chain CDR3 regions was observed between the two expansion protocols. Notably, 
the single exclusive group of Vδ chains was found in freshly isolated γδT cells, indicating a significant shift in Vδ 
chain CDR3 repertoire post expansion. Striking homology in CDR3 spectratypes was observed in the Vγ9 and 
Vδ2 chains of E. coli and zoledronate-expanded γδT cells, confirming CDR3 overlap (Fig. 3G).
γδT cell acquisition of phagocytic capacity is concurrent with sustained upregulation of cell sur-
face HLA-DR and CD86.  We hypothesized that opsonization-mediated phagocytosis is associated with 
acquisition of APC capabilities by γδT cells. To test this, expression of classic APC markers, HLA-DR and CD86, 
was investigated. E. coli mediated a steady increase in both markers, with a majority of expanding γδT cells devel-
oping an HLA-DRposCD86pos phenotype within 7 days of stimulation (Fig. 4A,B). HLA-DR and CD86 expression 
on expanded γδT cells was similar to that observed on freshly isolated monocytes (CD3negCD14pos PBMC). αβT 
cells remained negative for both markers throughout expansion (Fig. 4B). Following overnight stimulation with 
E. coli, γδT cells upregulated the lymphoid-homing chemokine receptor CCR7 which persisted up to 7 days of 
culture (Fig. 4A,B). When positive, CCR7 levels on γδT cells were similar to those on naïve, unstimulated αβT 
cells. (Fig. S4). As noted with phagocytic measurements, HLA-DR, CD86 and CCR7 expression on γδT cells were 
similar between E. coli and zoledronate-expanded cells (data not shown).
γδT cells develop a pAPC phenotype whilst maintaining cytotoxicity and losing a TCR-dependent 
Th1 inflammatory phenotype.  To assess the γδT cell cytokine and cytotoxic profile concurrent with the 
acquisition of a pAPC phenotype, freshly isolated PBMC were cultured with or without UV-irradiated E. coli at 
MOI 10 and either analyzed after overnight (16–18 h) culture or left to expand in IL-2-supplemented media for 
14 days, and re-stimulated with E. coli overnight on day 14. E. coli mediated potent upregulation of cell surface 
CD69 and CD107a, as well as marked accumulation of intracellular IFN-γ and TNF-α after overnight stimulation 
of γδT cells within freshly isolated PBMC, which was not seen when PBMC were mock stimulated with IL-2 media 
alone (representative donor data is shown in Fig. 5A). These effector responses exhibited high consistency between 
different donors (Fig. S5A and B). While a majority of γδT cells were IFN-γposCD107apos, a significant fraction 
exhibited a single positive IFN-γpos or CD107apos phenotype (Fig. S5C); these were later found to be Vδ2+ and Vδ1+ 
cells, respectively (Fig. S5E). No IL-17 or IL-10 production could be detected by FACS or ELISA (data not shown). 
Approximately 65% of unstimulated γδT cells were granulysinpos, and this proportion did not alter significantly 
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Figure 3. E. coli and Zoledronate-expanded γδT cells phagocytose E. coli with similar dynamics in a TCR-
dependent manner. Freshly-isolated PBMC (n = 5) were expanded with UV-irradiated E. coli or zoledronate 
for 14 days, and examined for E. coli uptake on day 14. To determine uptake, PBMC were incubated with 
IgG-opsonized E. coli for 60 min. PBMC were pre-cultured with normal media (control), anti-γδTCR mAb 
(clone: B1) or isotype-matched control. The effect of pre-culture with anti-γδTCR mAb on phagocytosis 
was examined; data is shown for (A) E. coli-expanded or (B) zoledronate-expanded γδT cells, incubated 
with FITC-E. coli or pHrodo-E. coli. (C) PBMC were incubated with opsonized green fluorescent beads and 
quenched post-culture with Trypan Blue. Shown are representative stains, gated on γδT cells: i) non-quenched 
co-culture indicating total bead fluorescence (black, solid, unshaded), ii) quenched co-culture indicating 
intracellular bead fluorescence (red, dotted, unshaded), iii) cells alone (gray, shaded). (D) The effect of anti-
γδTCR mAb was examined on γδT cell uptake of opsonized bead in quenched and non-quenched samples 
(n = 3). (E) TCR sequencing was carried out on E. coli or zoledronate-expanded and fresh non-expanded γδT 
cells. Representative heat maps of one donor E. coli and zoledronate-expanded γδT cell Vγ (VG), Vδ (VD) and 
Vj (VJ) chain reads are shown. (F) The number of shared TCR CDR3 sequences was tallied and compared in 
E. coli or zoledronate-expanded and fresh unexpanded γδT cells. A comparison of the number of sequencing 
reads shared as well as the number of unique sequences in each category is shown for both Vγ and Vδ TCR 
chains. For all samples, total depth of sequencing was equivalent. Only sequences with more than 5000 reads 
were tallied to select for the commonest clones. (G) TCR CDR3 spectratyping was carried out for E. coli or 
zoledronate-expanded Vγ9Vδ2 T cells. Representative spectratypes of one donor are shown.
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during mock or E. coli co-culture (Fig. 5A,B). αβT cells exhibited a low degree of CD107a-mediated cytotoxic 
degranulation in response to E. coli stimulation, but not upregulation of CD69, IFN-γ or TNF-α (Fig. S5D). Whilst 
Vδ2+ and Vδ1−Vδ2− γδT cell populations were significant cytokine producers, Vδ1+ cells exhibited a significantly 
more potent cytotoxic response as measured by granulysin and CD107a expression (Fig. S5E). CD69 expression was 
markedly higher on Vδ2+ cells compared to other γδT cell subsets (Fig. S5E).
Following expansion with E. coli, γδT cells exhibited a significantly decreased cytokine (IFN-γ, TNF-α) 
response to E. coli, and decreased CD69 expression compared to that observed in freshly isolated γδT cells. IL-17, 
IL-10 or TGF-β were undetectable in E. coli-expanded γδT cells (data not shown). E. coli-expanded γδT cells did, 
however, continue to exhibit CD107a-mediated cytotoxic degranulation and presence of granulysin, albeit at 
lower levels compared to freshly isolated γδT cells (Fig. 5B). These observations may partially be attributed to the 
loss of the highly cytotoxic Vδ1+ subset after expansion (Fig. 5E). Interestingly, γδT cell expansion with zoledro-
nate resulted in a similar loss of cytokine production capacity post-expansion, whether stimulated with E. coli or 
re-stimulated with zoledronate (data not shown). The decrease in cytokine production was not associated with a 
shift in memory phenotype or exhaustion marker expression (Fig. S6A), nor could it be attributed to the absence 
of non-T cell “helper” cells in expanded PBMC (Fig. S7). We, thus, concluded that the altered cytokine profile of 
expanded versus freshly isolated γδT cells represents a true phenotypic shift.
Exposure to anti-γδTCR mAb prior to co-culture of freshly-isolated PBMC with E. coli led to abrogation of 
CD69 upregulation, cytokine production (Fig. 5D) and a decrease in the double positive IFN-γposCD107apos but 
not in single positive CD107apos γδT cell populations (Fig. S2C). The decrease in IFN-γposCD107apos γδT cells was 
subset-specific, as only Vδ2+ but not Vδ1+ γδT cell cytotoxic degranulation was sensitive to a pre-blocked TCR 
(Fig. 5E). To evaluate direct cytotoxicity against E. coli, FACS-sorted E. coli-expanded γδT cells (predominantly 
with a Vδ2+ TCR) were pre-treated with blocking anti-γδTCR mAb and exposed to live bacteria; cytotoxicity 
was inferred from residual colony numbers on agar plates. Remarkably, E. coli colony forming unit (CFU) count 
declined by >90% within 30 minutes; this effect was not dependent upon γδTCR engagement (Fig. 5F). The high 
efficiency of bactericidal activity was observed for both E. coli and zoledronate-expanded γδT cells (Fig. 5G). 
Although γδTCR blocking showed no impact on bactericidal function, it completely blocked γδT cell prolifera-
tion in response to E. coli (Fig. 5H).
Discussion
Recent studies have attested to the pAPC capacity of peripheral human γδT cells. Vγ9Vδ2T cells are able to 
process and present peptide antigens by MHC class II in a ‘professional’ way to naïve CD4+ T cells22, and to 
cross-present antigens on MHC class I to CD8+ T cells31, both reminiscent of myeloid DC. We have previously 
shown that, following short term activation, freshly isolated human γδT cells can phagocytose bacteria and syn-
thetic beads, and subsequently process and present associated antigens to αβT cells23, 24. Further support for these 
Figure 4. γδT cell acquisition of phagocytic capacity is concurrent with sustained upregulation of cell surface 
HLA-DR and CD86, but not CCR7. Freshly-isolated PBMC (n = 5) were expanded for 14 days with irradiated 
E. coli, and stained for cell surface HLA-DR, CD86 and CCR7 throughout expansion. (A) Representative stains 
of one donor γδT cells is shown, with specific antibody in black, unshaded, and isotype-matched control - in 
gray, shaded. (B) HLA-DR, CD86 (left column) and CCR7 (right column) MFI over expansion was compared 
between γδT, αβT cells and monocytes (CD3negCD14pos PBMC).
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Figure 5. γδT cell development of a pAPC phenotype is parallel to maintenance of cytotoxicity, but leads to loss of 
a TCR-dependent Th1 inflammatory phenotype. Freshly-isolated PBMC (n = 5) were stimulated with E. coli and 
analyzed after overnight (16–18 h) culture or left to expand for 14 days, and re-stimulated with E. coli overnight on 
day 14. γδT cell accumulation of intracellular IFN-γ, TNF-α, granulysin, and cell surface CD69 and CD107a were 
assessed via FACS analysis. (A) Freshly-isolated PBMC were analyzed unstimulated, after overnight stimulation 
with E. coli or IL-2 alone (mock). Representative stains of one donor are shown, gated on γδT cells, with specific 
antibody in black, unshaded, and isotype-matched control in gray, shaded. (B) Parameter MFI in response to E. coli 
and mock stimulation were compared between freshly-isolated and 14 day E. coli-expanded γδT cells. (C) Stains of 
five representative donors are shown for cell surface CD107a in response to E. coli or mock stimulation, comparing 
fresh and E. coli-expanded γδT cells. (D) Freshly-isolated PBMC were cultured for 2 h with blocking anti-γδTCR 
mAb or isotype-matched control. Representative IFN-γ, TNF-α and CD69 staining of one donor, gated on γδT cells, 
are shown on the left. A compilation of donor parameter MFI is shown on the right. (E) The effect of anti-γδTCR 
mAb on fresh γδT cell surface CD107a is shown for five representative donors, comparing Vδ1+ and Vδ2+ cells. (F) 
E. coli-expanded, FACS-purified γδT cells were pre-blocked with anti-γδTCR mAb, isotype control or normal media 
(control) prior to co-culture with live E. coli. At designated time points the co-culture was lysed in H2O, and plated on 
agar for overnight growth; resulting E. coli CFU were counted. (G) E. coli and zoledronate-expanded, FACS-purified 
γδT cells were co-cultured with live E. coli. Remaining E. coli CFU were counted. (H) Proliferation in response to E. 
coli stimulation was observed in γδT cells pre-blocked with anti-γδTCR mAb.
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observations was recently provided in a study investigating phagocytosis of Listeria monocytogenes by peripheral 
human γδT cells16. In parallel, numerous clinical studies indicate that human peripheral γδT cells expand signif-
icantly and transiently, and acquire the above-described pAPC features following bacterial and parasitic infec-
tions4, 18–21, 32. We have bridged these in vitro and in vivo clinical observations of human γδT cell functions using 
an ex vivo model system, where PBMC were cultured with E. coli to reflect features of in vivo acute bacteremia. 
In particular, we attempted a reconciliation of the plethora of described human γδT cell functions, ranging from 
IFN-γ production and cytotoxicity to phagocytosis and pAPC functions. We evaluated direct cytotoxicity, TCR 
dependency, and subtype specificity of these functions in order to understand whether γδT cells are able to kill 
directly their own microbial targets for uptake and subsequent processing, and what relationship this bears to 
their pAPC phenotype.
E. coli exposure led to potent TCR-dependent freshly-isolated γδT cell IFN-γ and TNF-α production, as well 
as substantial cytotoxic degranulation and bacterial killing. The ensuing, primarily Vγ9Vδ2, γδT cell prolifera-
tion/expansion was marked by concomitant upregulation of cell surface HLA-DR and CD86, and an increase in 
TCR-dependent bacterial phagocytic activity which was markedly enhanced by IgG opsonisation. Importantly, 
phagocytosis was accompanied by acidification, indicating delivery of target to the lysosomal compartment. The 
latter process was not seen during co-culture with αβT cells. Development of γδT cell pAPC phenotype was 
accompanied by a loss of cytokine production while maintaining cytotoxic degranulation and bactericidal activity. 
Curiously, purified expanded Vδ2+ cells exhibited high bactericidal activity despite decreased CD107a-mediated 
cytotoxic degranulation and blocking of the TCR (Fig. 5C,E and F). This may be attributable to the high effi-
ciency of γδT cell CD107a-mediated E. coli killing, whereupon low level degranulation is sufficient to significantly 
decrease bacterial viability, or may allude instead to further CD107a-independent bactericidal mechanisms.
Overall, no significant difference in E. coli versus zoledronate expanded γδT cell function was observed. TCR 
sequencing and spectratyping revealed that TCR repertoires were strikingly similar, while differing significantly 
from fresh, unexpanded γδT cells, consistent with focusing of the repertoire on a common set of TCR ligands. 
We conclude that peripheral human Vγ9Vδ2 γδT cells transition from early TCR-dependent IFN-γposTNF-αpos, 
cytotoxic responders to TCR-dependent IFN-γnegTNF-αneg, cytotoxic, phagocytic pAPCs. We were intrigued to 
discover that both uptake and acidification of opsonized E. coli by E. coli-expanded γδT cells was significantly 
inhibited by a γδTCR-blocking antibody (Fig. 3A); similar, although less marked, blocking was observed in 
zoledronate-expanded γδT cells (Fig. 3B). In addition, γδT cell uptake of material was inhibited by CyD, indicat-
ing a requirement for rearrangement of the actin cytoskeleton, as described in macrophages and DC33–35. A pre-
vious study demonstrated that TCR internalization by Jurkat T cells involved phagocytosis of MHC-containing 
membrane patches originating from an immunological synapse. In this αβT cell line the phagocytosed material 
was reported to be re-routed to the membrane rather than subjected to acidification and antigen processing36. 
Our observations support this published data as the subpopulation of residual αβT cells following E. coli stim-
ulation acquired minor uptake but no acidification of internalized material (Fig. 2F,H). It is possible that some 
γδT cell phagocytosis involves a similar mechanism, recruiting phagocytising machinery to the immune synapse.
Given our data comparing the development of this phenotype in E. coli versus zoledronate-expanded γδT 
cells, we suggest that these results altogether may indicate one of the following mechanisms of TCR involvement 
in uptake: i) the γδTCR engages E. coli and beads directly, ii) E. coli and opsonized beads stress PBMC sufficiently 
to lead to the upregulation of stress markers, such as BTN3A/CD27726, which then provide a stimulatory signal to 
the γδTCR, iii) tonic TCR signaling is required for γδT cell phagocytosis, iv) interaction between TCR and FcγR, 
which may be disrupted by γδTCR blocking, is necessary for productive engagement of phagocytic machinery. 
Comprehensive further study is needed to determine the exact involvement of the TCR in γδT cell phagocytosis 
and further effector functions, and will benefit particularly from the examination of the role of BTN3 molecules 
in these processes.
It has been proposed that zoledronate activates γδT cells by causing accumulation of endogenous pyrophos-
phates and, consequently, conformational changes in butyrophilin molecules such as BTN3A26. Like zoledronate, 
E. coli too causes accumulation of endogenous pyrophosphates (IPP), which then serves to drive activation and 
proliferation of Vγ9Vδ2 T cells18, 37. E. coli further expresses HMBPP, a known inducer of BTN3A/CD277 con-
formational changes suggesting that the signal recognized by the Vγ9Vδ2 TCR is the same following IPP and 
HMBPP stimulation38. This may be a decisive factor in producing the γδT cell populations so closely related in 
terms of CDR3 sequences and effector function we observed following PBMC stimulation with E. coli versus 
zoledronate. Related to this is the observation that the recognition of phosphoantigen signals appears to occur 
primarily through germline-encoded regions of the Vγ9Vδ2 TCR, and involves all CDR loops39. Relative to the 
αβTCR, there are, moreover, relatively few germline genes available for assembly of the γδTCR40. It has been 
postulated that the expansion of the Vγ9Vδ2 subset in the periphery after birth is driven by exposure to environ-
mental microbial ligands41.
TCR-engagement as a pre-requisite of phagocytosis (and other pAPC functions) suggests careful regulation of 
the Vγ9Vδ2 T cell compartment. Whenever an early immune response is sufficient to neutralize infection, MHC 
class IIposCD86pos Vγ9Vδ2 cells may be prevented from posing an unnecessary inflammatory threat by amplifying 
responses further through downregulation of their early cytokine responsiveness. The requirement for opsoniza-
tion of a target may be a further safety feature23. This could be operative at two levels: i) as herein, when opsoniz-
ing with isotype-switched target-specific IgG, ii) in a ‘naïve’ non-immune situation, where natural antibodies 
(NAb) of different isotype, including IgG, may be involved. We have previously demonstrated that NAb can 
enhance DC uptake and antigen presentation of viruses42. Further study of the engagement of the Vγ9Vδ2 TCR, 
possibly with BTN3 targets, is likely to carry significant implications for γδT cell anti-tumor immunity by sup-
porting the notion that stress recognition, particularly in combination with Ab-opsonisation, may be sufficient 
not only for killing of a tumor cell but also for uptake, processing and presentation of tumor-associated antigens23.
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γδT cell direct killing of cellular and/or microbial targets combined with inflammatory cytokine production, 
followed by uptake of the target into acidifying antigen processing compartments, raises a novel paradigm. It 
is tantalizing to hypothesize that the combination of innate-like recognition and killing followed by myeloid 
cell-like phagocytosis by a lymphocyte-like cell may evolutionarily have preceded the full development of T 
lymphocyte-mediated adaptive immunity. Interestingly, the raised hypothesis is supported by previous studies 
showing that γδTCR chain genes may have preceded the development of αβTCR chain genes43. In addition, the 
existence in jawless fish of three lymphocyte-like cells expressing variable lymphocyte receptors (VLR) instead of 
TCR or BCR chain genes also supports this contention, since they otherwise resemble αβT, γδT and B cells by the 
expression of other orthologous genes44.
Materials and Methods
Study design. This study was designed to test the hypothesis that human γδT cells change phenotype fol-
lowing expansion initiated by exposure to E. coli. During the study we further hypothesised and tested whether 
blocking of the TCR on the cells would affect the phenotypic and functional changes. Sample numbers for cell 
expansions were 5 for most of the experiments. This number was chosen from previous and early experience in 
this study of known phenotypic variations between donors, in order to accurately reflect these variations. All 
experiments were repeated at least once, with the exception of DNA sequencing and spectratyping. However, 
these were done as separate experiments and the DNA sequencing of each clonotype included in the analy-
ses were represented by multiple individual reads. All experiments using peripheral blood-derived cells were 
performed in accordance with relevant guidelines and regulations, and were approved by UCL Research Ethics 
Committee. Informed consent was obtained from all volunteer blood donors.
Samples and cell preparation. PBMC from healthy adult donor peripheral blood were routinely extracted 
via Ficoll density gradient separation. Cells were cultured in supplemented RPMI 1640 media at a density of 
1.5 × 106 cells/mL at 37 °C and 5% CO2. Supplemented culture media contained RPMI 1640-GlutaMax (Life 
Technologies), 10% foetal calf serum, 1% Penicillin/Streptomycin (Life Technologies), 10 mM HEPES buffer 
(Life Technologies), 1 mM Sodium Pyruvate (Life Technologies) and 1x MEM non-essential amino acids (Life 
Technologies). All stimulation studies, unless explicitly specified, further included 100 IU/mL recombinant 
human IL-2 (MACS Miltenyi); media was re-adjusted every two to three days.
Growth and preparation of E. coli DH5α. E. coli (Thermo Fisher) were grown overnight at 37 °C shaking 
culture in 1 mL ampicillin (Life Technologies)-supplemented LB media (Sigma) from cryogenically preserved ali-
quots. Once amplified, E. coli culture was washed thoroughly and assessed for colony-forming unit (CFU) count 
via duplicate measurement of suspension optical density (OD). With the exception of killing assays, all bacteria 
employed in co-culture experiments were irradiated in a trans-illuminator chamber (UVITEC), equipped with 
eight UV-C (250–280 nm) lamps.
PBMC stimulation with UV-irradiated E. coli. Freshly isolated or expanded 1.5 × 106 cells/mL PBMC 
were co-cultured with E. coli (MOI 10) in supplemented RPMI 1640 media, and cultured overnight (16–18 h) 
or left to expand for 14 days. Re-stimulation of expanded PBMC with E. coli was carried out by mixing 14 day E. 
coli-expanded PBMC with irradiated E. coli at MOI 10. Re-stimulation of expanded PBMC with E. coli in the presence 
of freshly-isolated autologous PBMC was carried out by mixing FACS-stained 14 day E. coli-expanded PBMC with 
freshly-isolated unstained autologous PBMC at a ratio of 1:10 prior to the addition of irradiated E. coli at MOI 10.
PBMC stimulation with zoledronate.  Freshly isolated 1.5 × 106 cells/mL PBMC were cultured in 5 μM 
zoledronic acid monohydrate (zoledronate; Sigma-Aldrich) in supplemented RPMI 1640 media, and cultured for 
14 days. Re-stimulation of expanded PBMC with E. coli was carried out by mixing 14 day E. coli-expanded PBMC 
with irradiated E. coli at MOI 10.
PBMC surface marker expression and intracellular cytokine staining by flow cytometry.  PBMC 
were stained for cell viability, surface markers, intracellular cytokines and cell surface CD107a throughout stimu-
lation and expansion as indicated in supplied commercial protocols. Intracellular cytokine and CD107a staining 
was carried out on overnight stimulated PBMC that were cultured for a further 4 h in the presence of monensin 
(BioLegend). Colour compensation was carried out using OneComp eBeads (eBioscience). FACS analysis was 
performed on the Becton Dickinson (BD) LSR II and data processing - on FlowJo vX.07 software. The following 
antibody conjugates were used in PBMC staining: CD3-PE/Dazzle594 (BioLegend; clone: UCHT1), αβTCR-PE 
(BioLegend; clone: IP26), αβTCR-PE/Vio770 (MACS Miltenyi; clone: BW242/412), γδTCR-PE/Vio770 
(MACS Miltenyi; clone: 11F2), Vδ1-FITC (Thermo Fisher; clone: TS8.2), Vδ1-APC (MACS Miltenyi; clone: 
REA173), Vδ2-PerCP (Biolegend; clone: B6), Vδ2-PE (Biolegend; clone: B6), IFN-γ-PE (BioLegend; clone: B27), 
TNF-α-APC (BioLegend; clone: MAb11), IL-17-Brilliant Violet 605 (BioLegend; clone: BL168), CD69-PerCP 
(BioLegend; clone: FN50), IL-10-FITC (Affymetrix eBiosciences; clone: BT-10), granulysin-PE (BioLegend; 
clone DH2), CD107a-FITC (BioLegend; clone: H4A3), CCR7-PE (R&D Systems; clone: 150503), CD27-APC/
Vio770 (Miltenyi Biotec; clone: M-T271), CD45RA-FITC (BioLegend; clone: HI100), HLA-DR (MHC II)-APC/
Cy7 (BioLegend; clone: L243), CD86-APC (MACS Miltenyi; clone: FM95). Mouse IgG1κ of known, irrelevant, 
non-human specificity served as isotype control (BioLegend; clone: MG1-45). All FACS data presented subse-
quently is on singlet, live lymphocytes. The gating strategy employed in analysis is shown in Fig. S1.
γδT cell sorting by flow cytometry.  Day 14 expanded PBMC, with a predominantly γδT cell content, 
were purified further using flow sorting on the LSR II to >98% purity. Prior to the sort, PBMC were stained for 
expression of CD3 with CD3-PE/Dazzle594 (BioLegend; clone: UCHT1) and αβTCR with αβTCR-PE/Vio770 
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(MACS Miltenyi; clone: BW242/412). γδT cells were sorted for as CD3posαβTCRneg PBMC, gated as shown in 
Fig. S1. Bright fluorophores were used to maximize the clear separation of expanded αβT and γδT cells. Samples 
of purified γδT cells were stained as described above post-sort for further γδT cell markers including Vδ2 and 
γδTCR to establish purity. γδT cells were sorted into 50% foetal calf serum and cultured overnight in complete 
RPMI 1640 prior to use in functional assays.
E. coli opsonization.  E. coli were opsonized with commercially available highly purified anti-E. coli rabbit serum 
IgG (Escherichia coli BioParticles Opsonizing Reagent from Thermo Fisher) according to commercial protocol.
Confocal microscopy imaging of γδT cell uptake of E. coli. Imaging was performed on a Zeiss 
AxioObserver LSM 710 confocal microscope. FACS-purified 14 day zoledronate-expanded γδT cells were incu-
bated with IgG-opsonized, IPTG-inducible GFP-expressing E. coli (Thermo Fisher) for 60 min, placed on ice and 
fixed. Cells were then fluorescently labeled, deposited on cleaned coverslips and mounted on glass slides using 
ProLong Gold antifade mountant (Thermo Fisher) and cured in the dark at room temperature for 24 h. Images 
of cell conjugates were acquired with a 63× Plan-Apochromat oil objective, numerical aperture 1.4. Acquisition 
was optimized for subsequent deconvolution with Huygens software, using appropriate voxel sizes according to 
the Huygens Nyquist calculator.
Imaging flow cytometry of γδT cell uptake of polystyrene beads.  Imaging was performed on an 
Image StreamMark II flow cytometer (Amnis). Prior to analysis, 14 day zoledronate-expanded γδT cells were 
incubated with protease-sensitive DQ-Green (Thermo Fisher), BSA-labelled opsonized or non-opsonized pol-
ystyrene beads 0.5 μm or 1.0 μm in size (Polysciences) for 60 min, fixed and stained for cell surface markers. 
The opsonin used was Rituximab, a monoclonal, chimeric human-mouse IgG (Hoffman La Roche). The mode 
of opsonisation was passive adsorption of antibody to the bead, according to commercial protocol as supplied 
by Thermo Fisher. Post-acquisition data analysis was performed using IDEAS software (Amnis). ImageStream 
internalisation scores (IS) were generated by IDEAS software as described in commercially supplied protocol. 
Briefly, IS is defined as the ratio of fluorescence intensity inside the cell to the intensity of the entire cell. The inside 
versus outside of the cell is judged by application of an internal mask based on the brightfield image that covers 
the inside of the cell, the thickness of the cell membrane in pixels and the fluorescence channel of interest, while 
the external region is determined by dilating the internal mask by the membrane thickness and combining this 
with the object mask of the channel of interest.
E. coli-FITC uptake assay.  A FITC-Trypan Blue quenching assay was employed to assess PBMC uptake of 
E. coli. Briefly, UV-irradiated E. coli DH5α were FITC labeled by a gentle shaking in a saturated FITC isomer I 
(Sigma)-PBS solution for 1 h at 37 oC, followed by washing prior to co-culture with fresh or expanded PBMC at 
MOI 10. PBMC were co-cultured in triplicate for 60 min at 37 °C in a 5% CO2 incubator. Cells were then fixed 
in cold fixation buffer (Biolegend) before quenching with 0.4% Trypan Blue solution (Sigma-Aldrich) to remove 
extracellular FITC signal. After quenching, PBMC were washed three times in a large volume of PBS and ana-
lyzed using flow cytometry, as described previously by Busetto, et al.45 Each sample of quenched PBMC-E. coli 
mixture was treated in parallel to a non-quenched sample of the same origin to ensure that quenching had taken 
place. A quenched PBMC sample incubated with non-FITCylated E. coli was used as a control for background 
FITC fluorescence. In order to determine the involvement of actin polymerization in E. coli uptake, PBMC were 
pre-incubated in 0.2 mM CyD (Sigma), vessel control, DMSO (Sigma), or normal media.
E. coli-pHrodo acidification assay. An E. coli assay was employed to assess PBMC acidification 
of internalized bacteria according to supplied commercial protocol (available from “pHrodoTM Red and 
Green BioParticles® Conjugates for Phagocytosis” by Thermo Fisher Scientific). Briefly, supplied PFA-fixed, 
pHrodo-dyed E. coli (strain: K-12; product code: P35366) was re-suspended in a pH neutral isotonic buffer, HBSS 
(Life Technologies), and co-cultured with PBMC in triplicate in a 96-well plate for 60 min at 37 °C and 5% CO2. 
The media used in this assay was pre-warmed HBSS, sans IL-2. After co-culture, the culture was removed into 
cold fixation buffer. After fixation, PBMC were washed thoroughly and FACS stained for cell surface markers. 
Fixed and stained PBMC were then analyzed using flow cytometry. pHrodo dyes do not fluoresce at basic or 
neutral pH, but fluoresce strongly in proportion to pH drop below pH of 7. E. coli-pHrodo alone served as control 
for background pHrodo fluorescence. In order to determine the involvement of actin polymerization in bacterial 
acidification, PBMC were pre-incubated in 0.2 mM CyD, DMSO or normal media.
Green fluorescent bead uptake assay.  A green fluorescent bead-Trypan Blue quenching assay was 
employed to assess PBMC uptake of opsonized beads. Briefly, streptavidinylated (SA) ‘Dragon Green’ beads 
(Bangs Laboratories) were incubated with anti-SA rabbit mAb (GeneScript), washed and co-cultured in triplicate 
with PBMC for 60 min at 37 °C in a 5% CO2 incubator. Cells were then fixed in cold fixation buffer (Biolegend) 
before quenching with 0.4% Trypan Blue solution (Sigma-Aldrich) to reduce extracellular Dragon Green signal. 
After quenching, PBMC were washed three times in a large volume of PBS and analyzed using flow cytometry. 
Each sample of quenched PBMC-bead mixture was treated in parallel to a non-quenched sample of the same 
origin to ensure that quenching had taken place.
γδTCR blocking.  PBMC were co-incubated for 2 h with 10 μg/mL LEAF-purified anti-γδTCR mouse 
IgG1κ mAb (Biolegend; clone: B1), the blocking properties of which have been described by Correia, et al.46 or 
isotype-matched LEAF purified mouse IgG1κ mAb of known non-human specificity (BioLegend; clone: 
MG1-45).
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Sequencing of γδTCR CDR3.  RNA was extracted from 1 × 106 freshly-isolated, 14 day E. coli-expanded or 
zoledronate-expanded PBMC. cDNA synthesis and PCR amplification of the gamma and delta chain sequences 
was performed using a commercial kit (Irepertoire Illumina human gamma delta kit; Cat. No. HTDGI-01-P). 
Amplified, barcoded fragments were sequenced on an Illumina MiSEq to a depth of 250 paired ends. Analysis was 
performed using a commercial platform provided by Irepertoire®.
Spectratyping of Vγ9 and Vδ2 CDR3.  Spectratyping was used to determine CDR3 lengths for functional 
V-gamma 9 and V-delta 2 genes. RNA was extracted from 14 day E. coli-expanded or zoledronate-expanded 
PBMC. Following this, cDNA was synthesized using High Capacity RNA to cDNA (Thermo Fisher Scientific). 
With cDNA as the template, TCR V-delta 2 specific forward primer (TGAAAGGAGAAGCGATCGGT) or TCR 
V-gamma 9 specific forward primer (TGGAATGTGTGGTGTCTGGA), and a fluorescently labeled TCR C-delta 
(GACAAAACGGATGGTTTGG) or TCR C-gamma (GGGGAAACATCTGCATCAAG) reverse primer were 
used to amplify fragments of interest by PCR. Fragments were separated by size using capillary electrophoresis 
and analyzed by GeneMapper v3.7 software (Applied Biosystems).
γδT cell bactericidal activity against E. coli. γδT cells were purified from 14 day E. coli-expanded PBMC 
using FACS sorting to >98% purity. To mitigate the stress and potential TCR internalization in response to purifi-
cation, purified γδT cells were rested overnight in supplemented, antibiotic-free RPMI 1640 media. 1.5 × 106 cells/
mL γδT cells were then co-cultured with live, non-irradiated E. coli DH5α at MOI 10 for 15, 30, 60 or 90 minutes. 
At designated time points, PBMC-bacterial suspension was removed in duplicate into sterile-filtered, room tem-
perature distilled H2O, allowed to hypotonically lyse for 10 minutes (to account for possible uptake of bacteria by 
γδT cells) and then serially diluted in H2O to 10-6 of the original concentration. The dilution series was plated 
in duplicate onto LB agar plates and grown overnight. The number of colony forming units (CFU) was as a 
measure of bactericidal activity. To determine the involvement of the γδTCR in bacterial killing, γδT cells were 
pre-incubated for 2 h with anti-γδTCR mAb, isotype-matched control or normal media, as described above.
Statistical analysis. Where relevant, acquired data was evaluated statistically with paired or unpaired t tests 
without assumed consistent standard deviation. Statistical significance was assessed through the Holm-Sidak 
method of correcting for multiple comparisons. The results referred to as “significant” further in the text entail a 
P value of 0.05 or lower. The statistical and graphic analysis software employed was Prism 6.0.
Data availability statement. All data generated or analysed during this study are included in this pub-
lished article (and its Supplementary Information file). The new generation sequencing datasets generated during 
and analysed during the current study are not publicly available due to their considerable size, but are available 
from the corresponding author on reasonable request.
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